Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

June 03, 2015

Berlin, June 3, 2015—The global health system remains unprepared for mass disease epidemics, warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today, ahead of the G7 summit in Elmau, Germany.

May 26, 2015

GENEVA—Governments meeting in Geneva for the annual World Health Assembly raised the alarm today on the exorbitant rise in the price to vaccinate a child, and took a decisive step towards addressing the problem by passing a resolution that called for more affordable vaccines and greater transparency of vaccine prices.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

December 10, 2013

MSF is calling for increased scale-up of "viral load" HIV treatment monitoring in order to help improve people’s HIV treatment outcomes.

December 06, 2013

As trade ministers negotiating the TPP convene in Singapore this weekend for high-level talks aimed at securing a deal by the end of the year, MSF warns that the vital lifeline of affordable medicines that millions depend on could be severely constrained by the pact's terms.

December 03, 2013

MSF responds to the Global Fund's annoucement that it had received pledges totalling $12 billion for the next three years, falling short of its minimum target of $15 billion.

December 02, 2013

This week, MSF warned the Global Fund of the consequences of a new pricing intitative that could result in middle-income countries paying higher prices for medicines.

November 25, 2013

In several countries where MSF works—such DRC, Guinea, Central African Republic, Nigeria, South Sudan and Myanmar—timely treatment remains out of reach for the majority of people who need it.

November 19, 2013

As TPP negotiators gather to meet for the first time since the intellectual property chapter of the secret trade agreement was leaked last week, MSF is urging countries to stand strongly against the US government’s attack on access to affordable medicines.

October 30, 2013

PARIS/NEW YORK—Without a new approach to developing and pricing new tuberculosis (TB) medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis (DR-TB), warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the Union World Conference on Lung Health in Paris.

Pages